[From the Field]Google in 2015, PharmaResearch in 2025
PharmaResearch’s restructuring plan, echoing Google’s 2015 move, sparked a 17% share price drop as investors questioned dual listing and shareholder motives.
GC Genome's planned dual listing has sparked concerns over conflicts of interest between parent and subsidiary shareholders due to high intra-group transactions, with experts warning of potential negative impacts on share price and the Korea Discount.
#YonhapInfomax #GCGenome #DualListing #InternalTransactions #KoreaDiscount #ShareholderConflict #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=65339
[GC Genome Listing④] Parent-Subsidiary Conflict of Interest Issues
GC Genome's planned dual listing has sparked concerns over conflicts of interest between parent and subsidiary shareholders due to high intra-group transactions, with experts warning of potential negative impacts on share price and the Korea Discount.
Dongwon Group's Decision to Resolve Dual Listing - Considering 'Overwhelming Owner Control'?
Dongwon Group to delist Dongwon F&B, maintaining 78.9% ownership post-exchange, as part of strategy to enhance global food business and shareholder value
LS Addresses Dual Listing Controversy - Vice Chairman Noh-hyun Myung - 'We Will Ensure No Damage to Shareholder Value'
LS Group addresses dual listing concerns, emphasizing strategic growth and shareholder value preservation in upcoming subsidiary IPOs
Yonhap Infomax News